Cargando…
Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2
We investigated compounds selected by molecular docking to identify a specific treatment for COVID-19 that decreases the interaction between angiotensin-converting enzyme 2 (ACE2) and the receptor-binding domain (RBD) of SARS-CoV-2. Five compounds that interact with ACE2 amino acids Gln24, Asp30, Hi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325380/ https://www.ncbi.nlm.nih.gov/pubmed/34358993 http://dx.doi.org/10.1016/j.compbiomed.2021.104719 |